Biography

Dr. Kaushik Bharati, PhD, MIPHA, FRSPH (London) is a Public Health Consultant based in New Delhi, India. He obtained his PhD in Physiology with specialization in Vaccinology from the University of Calcutta in 2001. He carried out his doctoral work at the Calcutta School of Tropical Medicine. He did his Post-doctoral Fellowship from the Liverpool School of Tropical Medicine, UK, specializing in Immunology and Molecular Biology. He was formerly a Scientist at the National Institute of Immunology, New Delhi and a Senior Program Officer at the Translational Health Science and Technology Institute, Faridabad, NCR Delhi, India. He was also a Visiting Professor in the Departments of Physiology and Microbiology at Vidyasagar University, Midnapore, West Bengal, India. His major research areas include Virology, Public Health and Health Policy. He has published over 40 papers in reputed national and international journals and has also co-authored a book entitled "Basic Concepts in Immunology". He has delivered numerous invited lectures at national and international conferences. He is currently on the Editorial Board of 8 journals from India and UK. He is on the Peer-reviewer Panel of 12 Bio-medical journals from India, UK, USA, China, and Nigeria. He is also an External Examiner for PhD of the University of Calcutta and Lincoln University College, Malaysia. He is a Member of the Indian Public Health Association and a Fellow of the Royal Society for Public Health (London). He has received 13 awards for his research work from India, New Zealand, UK, and USA.

Area of Interest:

Medical Sciences

100%

Research Publications in Numbers

Books
0

Chapters
0

Articles
88

Abstracts
20

Selected Publications

Bharati, K., 2022. When will the COVID-19 pandemic end? Ind. J. Physiol. Allied Sci., 74: 19-24.
CrossRef | Direct Link |
Bharati, K., 2021. Padma awards 2021: Few doctors honoured despite battling COVID-19. Indian Sci. Cruiser, 35: 12-17.
CrossRef |
Bharati, K., 2021. COVID-19 vaccines: Current status and future prospects. Indian Sci. Cruiser, 35: 37-48.
CrossRef |
Jain, H., K. Bharati, A. Garg and S. Das, 2020. Will the COVID-19 pandemic have a silver lining? An Indian perspective. J. Clin. Diagn. Res., 14: AB04-AB07.
CrossRef | Direct Link |
Jain, H., K. Bharati, A. Garg and S. Das, 2020. Health strategies that could boost industrial productivity in India amidst the COVID-19 crisis. J. Clin. Diagn. Res., Vol. 14. 10.7860/JCDR/2020/10825.13820.
CrossRef | Direct Link |
Bharati, K., A. Garg and S. Das, 2020. Medical peer reviewing: Key points to keep in mind. J. Clin. Diagn. Res., 10.7860/JCDR/2020/19581.13607.
CrossRef | Direct Link |
Bharati, K., A. Garg and S. Das, 2020. Challenges in delivering optimal healthcare to COVID-19 patients: Focus on Delhi, India. J. Clin. Diagn. Res., Vol. 14. 10.7860/JCDR/2020/5365.14061.
CrossRef | Direct Link |
Bharati, K., 2020. What impact could the COVID-19 pandemic have on public health? Indian Sci. Cruiser, 34: 47-53.
CrossRef |
Bharati, K., 2020. History of coronaviruses: Why is it important in the context of COVID-19? Indian Sci. Cruiser, 34: 6-10.
CrossRef |
Bharati, K., 2020. Dr. Maharaj Kishan Bhan. Sci. Culture, 86: 335-336.
CrossRef | Direct Link |
Bharati, K., 2020. COVID-19 pandemic: Will a vaccine be available soon? J. Clin. Diagn. Res., 14: AB01-AB03.
CrossRef | Direct Link |
Kaushik, B., 2019. Tuberculosis vaccine development: Current status and future directions. J. Clin. Diagn. Res., 13: AB01-AB04.
CrossRef | Direct Link |
Jain, H. and K. Bharati, 2019. Why did chikungunya return with a vengeance? Int. J. Med. Rev. Case Rep., 10.5455/IJMRCR.Chikungunya-Return-with-Vengeance.
CrossRef | Direct Link |
Bharati, K., 2019. Why is the oral cholera vaccine underused in India? J. Clin. Diagn. Res., 10.7860/JCDR/2019/13050.13376.
CrossRef | Direct Link |
Bharati, K. and S. Das, 2019. Has violence against doctors become the norm in India? J. Clin. Diagn. Res., 10.7860/JCDR/2019/13567.13236.
CrossRef | Direct Link |
Gupta, S.S., K. Bharati, D. Sur, A. Khera, N.K. Ganguly and G.B. Nair, 2016. Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons. Indian J. Med. Res., 143: 545-551.
CrossRef | Direct Link |